Home › Trial NCT06503380
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
- Trial IDNCT06503380
- StatusRecruiting
- PhaseN/A
- Study typeObservational
- SponsorFudan University
- Enrollment1000
- Start date2024-07-15
- ConditionsHematological Toxicity · Targeted Therapy · Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.